TP
Thomas Patrick Kelly bought $560K of XENE stock
Thomas Patrick Kelly, Chief Financial Officer of Xenon Pharmaceuticals Inc. (XENE), bought 15,000 shares of XENE stock worth $560K, per an SEC Form 4 filed Oct 1, 2026.
It was an open-market purchase.
The trade happened on Sep 30, 2026, 1 day before it was made public.
XENE has moved +10.2% since the trade date, from $37.19 to $40.99 (Nov 12, 2026 close).
- Traded
- Sep 30, 2026
- Disclosed
- Oct 1, 2026
- Filing delay
- 1 day
- Price since
- +10.2%
- Role
- Chief Financial Officer
- Source
- SEC Form 4